Reata Pharma (RETA)
172.36 +0.04 (+0.02%) 09/26/23 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -311,901 | -297,386 | -247,752 | -290,170 | -80,546 |
| Depreciation Amortization | -2,177 | 7,766 | 8,681 | 2,306 | 1,319 |
| Accounts payable and accrued liabilities | 5,201 | 8,713 | 2,879 | -2,114 | 1,955 |
| Other Working Capital | 9,309 | -49,575 | -172,683 | 10,332 | -16,113 |
| Other Operating Activity | 95,301 | 94,781 | 86,535 | 28,495 | 9,602 |
| Operating Cash Flow | $-204,267 | $-235,701 | $-322,340 | $-251,151 | $-83,783 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 320,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -3,270 | -1,329 | -927 | -2,673 | -679 |
| Purchase Of Investment | -661,894 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-345,164 | $-1,329 | $-927 | $-2,673 | $-679 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 60,000 |
| Debt Repayment | N/A | N/A | -167,170 | 75,000 | N/A |
| Common Stock Issued | 1,485 | 9,138 | 351,098 | 505,898 | 235,381 |
| Other Financing Activity | 0 | 0 | 293,165 | -540 | -2,909 |
| Financing Cash Flow | $1,485 | $9,138 | $477,093 | $580,358 | $292,472 |
| Beginning Cash Position | 590,258 | 818,150 | 664,324 | 337,790 | 129,780 |
| End Cash Position | 42,312 | 590,258 | 818,150 | 664,324 | 337,790 |
| Net Cash Flow | $-547,946 | $-227,892 | $153,826 | $326,534 | $208,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -204,267 | -235,701 | -322,340 | -251,151 | -83,783 |
| Capital Expenditure | -3,270 | -1,329 | -927 | -2,673 | -679 |
| Free Cash Flow | -207,537 | -237,030 | -323,267 | -253,824 | -84,462 |